Formula Growth’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Formula Growth’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-54,350	Closed	-$2.62M	–	128
2024 Q2	$2.62M	Buy	+54,350	New	+$2.41M	0.95%	39

Other funds holding NARI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Formula Growth's NARI Position: Q3 2024 in Review

Formula Growth sold out of Inari Medical, Inc. Common Stock (NARI) in Q3 2024, closing a stake of 54,350 shares — an estimated $2.62M sold.

Formula Growth first reported a position in NARI in Q2 2024 and held it in 1 quarter. The position peaked at $2.62M in Q2 2024. 243 funds tracked by Wall St. Rank hold NARI as of Q3 2024.

Formula Growth reported no remaining Inari Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Formula Growth sold 54,350 Inari Medical, Inc. Common Stock shares in Q3 2024, an estimated $2.62M.
Formula Growth first reported a position in Inari Medical, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
Formula Growth's Inari Medical, Inc. Common Stock position peaked at $2.62M in Q2 2024.
243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q3 2024.

Based on Formula Growth's 13F filing for Q3 2024, filed 13 Nov 2024.